These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9877209)

  • 1. 4-iodotamoxifen aziridine, a new affinity labeling agent for the rapid detection of estrogen receptor isoforms.
    Maaroufi Y; Quivy J; Trivedi S; Gilot N; Leclercq G
    J Steroid Biochem Mol Biol; 1998 Oct; 67(2):95-104. PubMed ID: 9877209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
    Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen aziridine binding to cytosolic proteins from human breast specimens is negatively associated with estrogen receptors, progesterone receptors, pS2, and cathepsin-D.
    Navarro D; Doreste H; Cabrera JJ; Morales M; Díaz-Chico JC; Díaz-Chico BN
    Breast Cancer Res Treat; 1998 Jul; 50(2):155-66. PubMed ID: 9822220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neoplasia.
    Maaroufi Y; Trivedi S; Leclercq G
    Cancer Biochem Biophys; 1995 Nov; 15(2):67-78. PubMed ID: 8590437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM; Traish AM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.
    Trivedi S; Piccart M; Muquardt C; Gilot N; Hadiy S; Patel D; Leclercq G
    Breast Cancer Res Treat; 1996; 40(3):231-41. PubMed ID: 8883965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
    Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
    Salituro FG; Carlson KE; Elliston JF; Katzenellenbogen BS; Katzenellenbogen JA
    Steroids; 1986; 48(5-6):287-313. PubMed ID: 3445283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor.
    Harlow KW; Smith DN; Katzenellenbogen JA; Greene GL; Katzenellenbogen BS
    J Biol Chem; 1989 Oct; 264(29):17476-85. PubMed ID: 2793867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression.
    Borrás M; Hardy L; Lempereur F; el Khissiin AH; Legros N; Gol-Winkler R; Leclercq G
    J Steroid Biochem Mol Biol; 1994 Mar; 48(4):325-36. PubMed ID: 8142311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols.
    Piccart MJ; Muquardt C; Bosman C; Pirotte P; Veenstra S; Grillo F; Leclercq G
    J Natl Cancer Inst; 1991 Nov; 83(21):1553-9. PubMed ID: 1960752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity.
    Katzenellenbogen BS; Elliston JF; Monsma FJ; Springer PA; Ziegler YS; Greene GL
    Biochemistry; 1987 Apr; 26(8):2364-73. PubMed ID: 3620450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and selective photoaffinity labeling of the estrogen receptor using two nonsteroidal ligands that embody aryl azide or tetrafluoroaryl azide photoreactive functions.
    Pinney KG; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    Biochemistry; 1991 Mar; 30(9):2421-31. PubMed ID: 2001370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional estrogen receptors in a human preosteoclastic cell line.
    Fiorelli G; Gori F; Petilli M; Tanini A; Benvenuti S; Serio M; Bernabei P; Brandi ML
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2672-6. PubMed ID: 7708703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
    Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexestrol diazirine photoaffinity labeling reagent for the estrogen receptor.
    Bergmann KE; Carlson KE; Katzenellenbogen JA
    Bioconjug Chem; 1994; 5(2):141-50. PubMed ID: 8031877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size heterogeneity of affinity-labeled estrogen receptor in the ram hypothalamo-pituitary axis.
    Geffroy-Roisné S; Madigou T; Pelletier J; Thieulant ML
    Neuroendocrinology; 1993 Apr; 57(4):648-53. PubMed ID: 8367031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
    Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.